|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.250 USD | +1.63% |
|
-3.10% | -76.94% |
| 08-14 | Exicure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Exicure, Inc. Announces Board and Committee Changes, Effective June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXICURE, INC. | Bio Therapeutic Drugs | +1.63% | -3.10% | -76.94% | -75.00% | -99.40% | 8.05M |  |  | |
- Stock Market
- Stocks
- XCUR Stock
- Charts Exicure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
